Your browser doesn't support javascript.
loading
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.
Lips, Esther H; Kumar, Tapsi; Megalios, Anargyros; Visser, Lindy L; Sheinman, Michael; Fortunato, Angelo; Shah, Vandna; Hoogstraat, Marlous; Sei, Emi; Mallo, Diego; Roman-Escorza, Maria; Ahmed, Ahmed A; Xu, Mingchu; van den Belt-Dusebout, Alexandra W; Brugman, Wim; Casasent, Anna K; Clements, Karen; Davies, Helen R; Fu, Liping; Grigoriadis, Anita; Hardman, Timothy M; King, Lorraine M; Krete, Marielle; Kristel, Petra; de Maaker, Michiel; Maley, Carlo C; Marks, Jeffrey R; Menegaz, Brian A; Mulder, Lennart; Nieboer, Frank; Nowinski, Salpie; Pinder, Sarah; Quist, Jelmar; Salinas-Souza, Carolina; Schaapveld, Michael; Schmidt, Marjanka K; Shaaban, Abeer M; Shami, Rana; Sridharan, Mathini; Zhang, John; Stobart, Hilary; Collyar, Deborah; Nik-Zainal, Serena; Wessels, Lodewyk F A; Hwang, E Shelley; Navin, Nicholas E; Futreal, P Andrew; Thompson, Alastair M; Wesseling, Jelle; Sawyer, Elinor J.
Affiliation
  • Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kumar T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Megalios A; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Visser LL; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
  • Sheinman M; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Fortunato A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Shah V; Division of Molecular Carcinogenesis, Oncode Institute and The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hoogstraat M; School of Life Sciences, Arizona State University, Tempe, AZ, USA.
  • Sei E; Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ, USA.
  • Mallo D; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Roman-Escorza M; Division of Molecular Carcinogenesis, Oncode Institute and The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Ahmed AA; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Xu M; School of Life Sciences, Arizona State University, Tempe, AZ, USA.
  • van den Belt-Dusebout AW; Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ, USA.
  • Brugman W; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Casasent AK; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Clements K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Davies HR; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Fu L; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Grigoriadis A; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hardman TM; Screening Quality Assurance Service, Public Health England, London, UK.
  • King LM; Early Cancer Unit, Hutchison/MRC Research Centre and Academic Department of Medical Genetics, Cambridge Biomedical Research Campus, University of Cambridge, Cambridge, UK.
  • Krete M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kristel P; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • de Maaker M; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Maley CC; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Marks JR; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Menegaz BA; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mulder L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nieboer F; Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ, USA.
  • Nowinski S; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Pinder S; Department of Surgery, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Quist J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Salinas-Souza C; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schaapveld M; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Schmidt MK; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Shaaban AM; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Shami R; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Sridharan M; Division of Psychosocial research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Zhang J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Stobart H; Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK.
  • Collyar D; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Nik-Zainal S; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
  • Wessels LFA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hwang ES; Independent Cancer Patients' Voice, London, UK.
  • Navin NE; Patient Advocates in Research, Danville, CA, USA.
  • Futreal PA; Early Cancer Unit, Hutchison/MRC Research Centre and Academic Department of Medical Genetics, Cambridge Biomedical Research Campus, University of Cambridge, Cambridge, UK.
  • Thompson AM; Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, Delft, The Netherlands.
  • Wesseling J; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Sawyer EJ; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Genet ; 54(6): 850-860, 2022 06.
Article in En | MEDLINE | ID: mdl-35681052
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Ductal, Breast / Carcinoma, Intraductal, Noninfiltrating Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Ductal, Breast / Carcinoma, Intraductal, Noninfiltrating Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2022 Type: Article